Transfusion in coronary artery bypass grafting is associated with reduced long-term survival
- PMID: 16631651
- DOI: 10.1016/j.athoracsur.2005.12.037
Transfusion in coronary artery bypass grafting is associated with reduced long-term survival
Abstract
Background: Perioperative red blood cell (PRBC) transfusion has been associated with early risk for morbid outcomes, but risk related to long-term survival has not been thoroughly explored. Therefore, we examined the influence of PRBC transfusion and component therapy on long-term survival after isolated coronary artery bypass grafting after controlling for the effect of demographics, comorbidities, operative factors, and the early hazard for death.
Methods: The US Social Security Death Index was used to ascertain survival status for 10,289 patients who underwent isolated coronary artery bypass grafting from January 1, 1995 through June 28, 2002. The outcome measure was all-cause mortality during the follow-up period. Unadjusted survival estimates were performed using the Kaplan-Meier techniques. Survival curves for transfusion status were compared with the log-rank test. The parametric decomposition model was used for risk-adjusted survival. A balancing score was calculated for each patient and forced into the final model.
Results: Survival among transfused patients was significantly reduced as compared with nontransfused patients. The instantaneous risk of death displayed a biphasic pattern: a declining hazard phase from the time of the operation (early hazard) up until 6 months postoperatively and then a late hazard that continued out until about 10 years. Transfusion of red cells was associated with a risk-adjusted reduction in survival for both the early (0.34 +/- 0.02, p < 0.0001) and late phases (0.074 +/- 0.016, p < 0.0001).
Conclusions: Perioperative PRBC transfusion is associated with adverse long-term sequela in isolated CABG. Attention should be directed toward blood conservation methods and a more judicious use of PRBC.
Similar articles
-
Transfusion of red blood cells: the impact on short-term and long-term survival after coronary artery bypass grafting, a ten-year follow-up.Interact Cardiovasc Thorac Surg. 2010 Jan;10(1):37-42. doi: 10.1510/icvts.2009.214551. Epub 2009 Oct 8. Interact Cardiovasc Thorac Surg. 2010. PMID: 19815567
-
The effect on long-term survival of erythrocyte transfusion given for cardiac valve operations.Ann Thorac Surg. 2009 Jul;88(1):95-100, 100.e1-3. doi: 10.1016/j.athoracsur.2009.04.047. Ann Thorac Surg. 2009. PMID: 19559202
-
The impact of peripheral vascular disease on long-term survival after coronary artery bypass graft surgery.Ann Thorac Surg. 2008 Oct;86(4):1175-80. doi: 10.1016/j.athoracsur.2008.06.024. Ann Thorac Surg. 2008. PMID: 18805156
-
Persistent effect of red cell transfusion on health-related quality of life after cardiac surgery.Ann Thorac Surg. 2006 Jul;82(1):13-20. doi: 10.1016/j.athoracsur.2005.07.075. Ann Thorac Surg. 2006. PMID: 16798179
-
Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery.Eur J Cardiothorac Surg. 2005 Apr;27(4):592-8. doi: 10.1016/j.ejcts.2005.01.030. Eur J Cardiothorac Surg. 2005. PMID: 15784356
Cited by
-
Cost-Effectiveness and Budget Impact Analyses of Patient Blood Management in a Cardiovascular Surgery Department at Ankara Bilkent City Hospital in Turkey.Adv Ther. 2024 Feb;41(2):716-729. doi: 10.1007/s12325-023-02733-5. Epub 2023 Dec 19. Adv Ther. 2024. PMID: 38110651 Free PMC article.
-
The additive effects of anaemia and transfusion on long-term survival after coronary artery bypass surgery.Eur J Cardiothorac Surg. 2024 Mar 1;65(3):ezad403. doi: 10.1093/ejcts/ezad403. Eur J Cardiothorac Surg. 2024. PMID: 38058180 Free PMC article.
-
Acute Kidney Injury after Cardiac Surgery: Prediction, Prevention, and Management.Anesthesiology. 2023 Dec 1;139(6):880-898. doi: 10.1097/ALN.0000000000004734. Anesthesiology. 2023. PMID: 37812758 Review.
-
Loss or Dilution-A New Diagnostic Method to Assess the Impact of Dilution on Standard Laboratory Parameters.Diagnostics (Basel). 2023 Aug 4;13(15):2596. doi: 10.3390/diagnostics13152596. Diagnostics (Basel). 2023. PMID: 37568959 Free PMC article.
-
The effects of allogeneic and autologous blood transfusion on immune function in patients receiving total hip replacement.Am J Transl Res. 2023 Jul 15;15(7):4709-4717. eCollection 2023. Am J Transl Res. 2023. PMID: 37560247 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical